New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Takeda Pharmaceutical Company Limited
TAK
Shape
US Flag

NYSE

EPS improving

EPS improving

45B

Drug Manufacturers - Specialty & Generic

Next Earning date - 24 Oct 2024

45B

Drug Manufacturers - Specialty & Generic

Next Earning date - 24 Oct 2024

14.34USD
Shape0.04 ( 0.28%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-54%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated October 15, 2024
1W 0.42 % 1M -3.11 % 3M 7.82 % 1Y -2.65 %

Key Metrics

Shape
  • Market Cap

    45.46B


  • Shares Outstanding

    3.17B


  • Share in Float

    3.17B


  • Dividende

    0.58


  • Earning Date

    24 Oct 2024


  • Price Target

    14.34


  • Average Volume

    2.26M


  • Beta

    0.498


  • Range

    12.58-15.08


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.takeda.com


  • Sector

    Healthcare


Fundamentals

Shape

9.21x

P/E Ratio

1.54x

P/S Ratio

0.43x

P/B Ratio

0.7

Debt/Equity

3.4%

Net Margin

$0.3

EPS

How TAK compares to sector?

P/E Ratio

Relative Strength

Shape

TAK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4258B

Shape252%

2025-Revenue

$32.95

Shape-46%

2025-EPS

$1248B

Shape203%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Johnson Rice

initialise

Previous: Not converted

2024-09-10

Now: Buy

Guggenheim

initialise

Previous: Not converted

2024-07-24

Now: Buy

Bank of America Securities

upgrade

Previous: Not converted

2023-03-16

Now: Buy

Cowen & Co.

upgrade

Previous: Not converted

2022-07-19

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+16%

0.52
vs 0.45

Q4.22

arrow
arrow

-15%

0.46
vs 0.54

Q1.23

arrow
arrow

+3%

0.39
vs 0.38

Q2.23

arrow
arrow

-2%

0.55
vs 0.56

Q3.23

arrow
arrow

-4%

0.5
vs 0.52

Q4.23

arrow
arrow

+11%

0.51
vs 0.46

Q1.24

arrow
arrow

N/A

-0.01
vs 0.39

Q2.24

arrow
arrow

+2%

0.56
vs 0.55

Q3.24

arrow
arrow

+2539%

13.19
vs 0.5

Q4.24

arrow
arrow

+2038%

10.9
vs 0.51

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+19%

1002.3B  vs 844.8B

Q4.22

arrow
arrow

+22%

1096.6B  vs 901.3B

Q1.23

arrow
arrow

+9%

956.2B  vs 873.3B

Q2.23

arrow
arrow

+9%

1058.6B  vs 972.5B

Q3.23

arrow
arrow

+4%

1043.1B  vs 1002.3B

Q4.23

arrow
arrow

+1%

1111.2B  vs 1096.6B

Q1.24

arrow
arrow

+10%

1050.9B  vs 956.2B

Q2.24

arrow
arrow

+14%

1208B  vs 1058.6B

Q3.24

arrow
arrow

+1%

1050.5B  vs 1043.1B

Q4.24

arrow
arrow

-2%

1093.7B  vs 1111.2B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs 0.02

Q4.22

arrow
arrow

+2%

0.02
vs 0.01

Q1.23

arrow
arrow

+0%

0
vs 0.02

Q2.23

arrow
arrow

+1%

0.01
vs 0

Q3.23

arrow
arrow

-1%

-0.01
vs 0.01

Q4.23

arrow
arrow

+2%

0.02
vs -0.01

Q1.24

arrow
arrow

0%

-0.00
vs 0.02

Q2.24

arrow
arrow

+1%

0.01
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

276

276
vs 275

0%

Q4.22

arrow
arrow

286

286
vs 276

4%

Q1.23

arrow
arrow

305

305
vs 286

7%

Q2.23

arrow
arrow

318

318
vs 305

4%

Q3.23

arrow
arrow

317

317
vs 318

0%

Q4.23

arrow
arrow

312

312
vs 317

-2%

Q1.24

arrow
arrow

320

320
vs 312

3%

Q2.24

arrow
arrow

285

285
vs 320

-11%

Earnings Growth

Latest News